Use any of the search fields below to browse our clinical trials that are currently enrolling new patients. Each listing includes additional information about that specific trial. Please note that availability for trials can change, and a slot may not be immediately available at the time of inquiry. For more information about clinical trials, please call 215-214-1515 or or fill out this form to be connected with a Patient Navigator, who will be able to best assist you in the first steps of inquiry.


More information about clinical trials for study participants.


1-10 of 102 Results

Title Investigator Disease(s)

(Peak) A Study of Sunitinib +/- CGT9486 in Gastrointestinal Stromal Tumors (GIST)

[Protocol 22-1006]
Margaret von Mehren
  • Soft Tissue
  • (TrilynX): A Study of Debio 1143 + Chemoradiotherapy in Head and Neck Cancer

    [Protocol 20-1059]
    Jessica Bauman
  • Larynx
  • Lip, Oral Cavity and Pharynx
  • A Phase I Study of GNX102 in patients with Advanced Solid Tumors

    [Protocol 19-1043]
    Anthony Olszanski
  • Breast
  • Cervix
  • Colon
  • Corpus Uteri
  • Esophagus
  • Liver
  • Lung
  • Melanoma, Skin
  • Ovary
  • Pancreas
  • Prostate
  • Rectum
  • Stomach
  • Urinary Bladder
  • A Phase II Trial of Risk Enabled Therapy After Neoadjuvant Immunochemotherapy for Bladder Cancer

    [Protocol 20-1047]
    Pooja Ghatalia
  • Urinary Bladder
  • A Study of Elranatamab in Multiple Myeloma That Has Come Back After or Not Responded to Treatment

    [Protocol 21-1078]
    Asya Nina Varshavsky-Yanovsky
  • Multiple Myeloma
  • A Study of Maintenance Atezolizumab +/- Lurbinectedin in Extensive-Stage Small-Cell Lung Cancer

    [Protocol 21-1075]
    Hossein Borghaei
  • Lung
  • A Study of Pembrolizumab (MK-3475) +/- Belzutifan (MK-6482) in ccRCC

    [Protocol 22-1012]
    Pooja Ghatalia
  • Kidney
  • A Study of the oral KIT Inhibitor THE-630 in Advanced Gastrointestinal Stromal Tumors (GIST)

    [Protocol 21-1072]
    Margaret von Mehren
  • Soft Tissue
  • A Study to Evaluate Safety, Efficacy, and PK of EU101 in Participants With Advanced Solid Tumors

    [Protocol 21-1063]
    Anthony Olszanski
  • Anus
  • Bones and Joints
  • Breast
  • Cervix
  • Colon
  • Corpus Uteri
  • Esophagus
  • Ill-Defined Sites
  • Kidney
  • Larynx
  • Lip, Oral Cavity and Pharynx
  • Liver
  • Lung
  • Melanoma, Skin
  • Other Digestive Organ
  • Other Female Genital
  • Other Male Genital
  • Other Respiratory and Intrathoracic Organs
  • Other Skin
  • Other Urinary
  • Ovary
  • Pancreas
  • Prostate
  • Rectum
  • Small Intestine
  • Soft Tissue
  • Stomach
  • Thyroid
  • Unknown Sites
  • Urinary Bladder
  • A Trial of Surgery and Radiation, with Cisplatin vs Docetaxel +/- Cetuximab, in Head and Neck Cancer

    [Protocol RTOG1216]
    Thomas Galloway
  • Lip, Oral Cavity and Pharynx